Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2

Status

Recruiting 309Active not recruiting 188Completed 89Not yet recruiting 81Terminated 19Enrolling by invitation 15Withdrawn 8Suspended 3Available 2

Sponsor Class

OTHER 6INDUSTRY 2

Study Type

Interventional 5Observational 3

Sponsor

Cancer Type

Genitourinary 8

Conditions

Neoplasms 12Prostatic Neoplasms 8Recurrence 4Lung Neoplasms 4Breast Neoplasms 4Urinary Bladder Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Multiple Myeloma 3Lymphoma, B-Cell 3Lymphoma 3Colorectal Neoplasms 3Cancer Pain 3Uterine Cervical Neoplasms 2Urologic Neoplasms 2Triple Negative Breast Neoplasms 2Solid Tumor 2Small Cell Lung Carcinoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Ovarian Neoplasms 2Non-Muscle Invasive Bladder Neoplasms 2Neoplasm Metastasis 2Melanoma 2Lymphoma, Follicular 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Head and Neck Neoplasms 2Glioblastoma 2Cholangiocarcinoma 2

Interventions

ALT-803 2pembrolizumab 1Transurethral Resection of Prostate 1Surveys and Questionnaires 1Radiofrequency Ablation 1Physical Therapy Modalities 1Cryosurgery 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Withdrawn × Prostatic Neoplasms × 90 days × Clear all
NCT01673581 2026-05-15

Shared Decision Making in Low Risk Prostate Cancer

Massachusetts General Hospital

Withdrawn
Genitourinary

Prostatic Neoplasms

NCT04565496 2026-05-15

PEM-PRO

IRCCS San Raffaele

Phase 2 Withdrawn
Genitourinary

Prostatic Neoplasms

NCT07237399 2026-05-13

TA-P-OLIM

University Hospital, Ghent

Withdrawn
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT06765902 2026-05-05

Immunotherapy Before and After Surgery

ImmunityBio, Inc.

Phase 2 Withdrawn
Genitourinary

Prostatic Neoplasms

NCT06765954 2026-05-05

Immunotherapy With N 803, ETBX-071, and M-CENK in Combination With Radiation for Participants With High-Risk Prostate Cancer.

ImmunityBio, Inc.

Phase 2 Withdrawn
Genitourinary

Prostatic Neoplasms

NCT07541066 2026-04-21

Robotic Telesurgery in Urology

Case Comprehensive Cancer Center

Phase NA Withdrawn
Genitourinary

Prostatic Neoplasms

NCT06282185 2026-03-23

Superman

Canisius-Wilhelmina Hospital

Phase NA Withdrawn
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT04243473 2026-03-03

Biopsy Collection for Men Undergoing Brachytherapy for Prostate Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Withdrawn
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡